Immune checkpoint expression score is an independent prognostic biomarker in resectable non-small cell lung cancer

被引：0
|
作者：
Uso, Marta [1 ,2 ]
Jantus-Lewintre, Eloisa [2 ,3 ]
Sirera, Rafael [3 ]
Calabuig, Silvia [1 ,2 ]
Pastor, Enrique [4 ]
Forteza, Jeronimo [5 ]
Camps, Carlos [1 ,4 ]
机构：
[1] Univ Valencia, Valencia, Spain
[2] Fdn Invest Hosp Gen Univ Valencia, Valencia, Spain
[3] Univ Politecn Valencia, E-46022 Valencia, Spain
[4] Hosp Gen Univ Valencia, Valencia, Spain
[5] Inst Valenciano Patol, Valencia, Spain
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4330
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4330
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Rhesus CE expression is an independent prognostic factor in non-small cell lung cancer
    Schulze, Arik Bernard
    Schmidt, Lars Henning
    Baie, Lara
    Kuemmel, Andreas
    Mohr, Michael
    Hillmann, Hartmut
    Geissler, Georg
    Gorlich, Dennis
    Kelsch, Reinhard
    Wiewrodt, Rainer
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [32] PTPRD: A Positive Predictive Biomarker for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
    Shen, J.
    Zhou, H.
    Liu, J.
    Zhang, Y.
    Zhou, T.
    Hong, S.
    Zhao, Y.
    Yang, Y.
    Zhao, H.
    Huang, Y.
    Fang, W.
    Zhang, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S335 - S336
  • [33] Prognostic Immune Markers in Non-Small Cell Lung Cancer
    Suzuki, Kei
    Kachala, Stefan S.
    Kadota, Kyuichi
    Shen, Ronglai
    Mo, Qianxing
    Beer, David G.
    Rusch, Valerie W.
    Travis, William D.
    Adusumilli, Prasad S.
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5247 - 5256
  • [34] Evaluating PD-L1 as a Prognostic Biomarker in Surgically Resectable Non-Small Cell Lung Cancer
    Tuminello, S.
    Veluswamy, R.
    Gamarra, C.
    Flores, R.
    Van Gerwen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S887 - S887
  • [35] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [36] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
  • [37] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [38] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [39] Reflections on immune checkpoint inhibition in non-small cell lung cancer
    Leventakos, Konstantinos
    Mansfield, Aaron S.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 411 - 413
  • [40] Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis
    Pelletier, MP
    Edwardes, MDD
    Michel, RP
    Halwani, F
    Morin, JE
    CANADIAN JOURNAL OF SURGERY, 2001, 44 (03) : 180 - 188
12345